المؤلفون: Affandi, Alsya J., Olesek, Katarzyna, Grabowska, Joanna, Nijen Twilhaar, Maarten K., Rodríguez, Ernesto, Saris, Anno, Zwart, Eline S., Nossent, Esther J., Kalay, Hakan, de Kok, Michael, Kazemier, Geert, Stöckl, Johannes, van den Eertwegh, Alfons J. M., de Gruijl, Tanja D., Garcia-Vallejo, Juan J., Storm, Gert, van Kooyk, Yvette, den Haan, Joke M. M.

المصدر: Frontiers in immunology, 12:697840

مصطلحات موضوعية: cancer, COVID-19, CD169, COVID-19/immunology [MeSH], Flow Cytometry [MeSH], Siglec-1, nanovaccine, SARS-CoV-2/immunology [MeSH], monocyte, Lung Neoplasms/immunology [MeSH], CD8-Positive T-Lymphocytes/immunology [MeSH], Carcinoma, Pancreatic Ductal/immunology [MeSH], Immunology, CD8, Antigen Presentation/immunology [MeSH], Lymphocyte Activation/immunology [MeSH], Humans [MeSH], Monocytes/immunology [MeSH], Interferon-alpha/pharmacology [MeSH], Pancreatic Neoplasms/immunology [MeSH], Lipopolysaccharide Receptors/metabolism [MeSH], Influenza, Human/immunology [MeSH], Sialic Acid Binding Ig-like Lectin 1/metabolism [MeSH], Cells, Cultured [MeSH], antigen-presentation

Relation: https://repository.publisso.de/resource/frl:6478369; https://doi.org/10.3389/fimmu.2021.697840; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356644/

الاتاحة: https://repository.publisso.de/resource/frl:6478369
https://doi.org/10.3389/fimmu.2021.697840
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356644/